Linked Life Data

2915561

Source:http://linkedlifedata.com/resource/pubmed/id/2915561

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1989-3-17
pubmed:abstractText
The prognostic impact of histopathologic subtyping of pulmonary adenocarcinoma according to the World Health Organization classification was evaluated among 137 consecutive patients with radically resected stage I or II tumors. Median observation time in the 55 patients who are alive is 47 months (range 25 to 80). All tumors were subtyped, the most frequent being acinar adenocarcinoma (57% of patients), followed by bronchioloalveolar carcinoma (18%), solid carcinoma with mucus formation (14%), and papillary adenocarcinoma (12%). Patients having bronchioloalveolar carcinoma had the longest median survival (44 months), while survival was shortest for patients having solid carcinoma with mucus formation (median 10 months); in this latter group there were significantly fewer 1-year survivors compared with all other subtypes. Survival time was intermediate for patients having acinar and papillary adenocarcinoma (medians 31 and 32 months). Patients with solid carcinoma with mucus formation have an unfavorable prognosis and may be considered potential candidates for studies on adjuvant therapy, although the relative influence of other prognostic factors may be considered as well.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0022-5223
pubmed:author
pubmed:issnType
Print
pubmed:volume
97
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
245-51
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1989
pubmed:articleTitle
Prognostic implications of histopathologic subtyping in patients with surgically treated stage I or II adenocarcinoma of the lung.
pubmed:affiliation
Department of Oncology ONB, Finsen Institute, Copenhagen, Denmark.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't